Prescription drug · ANDA
Brimonidine Tartrate/Timolol Maleate NDC 68462-281
brimonidine tartrate and timolol maleate · Brimonidine tartrate 2 mg/mL; Timolol maleate 5 mg/mL · Solution/ drops · Ophthalmic · Glenmark Pharmaceuticals Inc., USA
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 68462-281-32 | 68462028132 | 1 BOTTLE, DROPPER in 1 CARTON (68462-281-32) / 10 mL in 1 BOTTLE, DROPPERMarketed from May 16, 2024 | |
| 68462-281-69 | 68462028169 | 1 BOTTLE, DROPPER in 1 CARTON (68462-281-69) / 5 mL in 1 BOTTLE, DROPPERMarketed from May 16, 2024 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Brimonidine Tartrate/Timolol Maleate
- Generic name (nonproprietary)
- brimonidine tartrate and timolol maleate
- Active ingredients
- Brimonidine tartrate — 2 mg/mLTimolol maleate — 5 mg/mL
- Dosage form
- Solution/ drops
- Route
- Ophthalmic
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 214987
- Marketing start
- Listing expires
- Other FDA classes
- Adrenergic alpha-Agonists (Mechanism)Adrenergic beta-Antagonists (Mechanism)
- Identifiers
- Product ID 68462-281_e97c8703-5166-49b6-8dd2-69c5b9dfcae8SPL ID e97c8703-5166-49b6-8dd2-69c5b9dfcae8SPL set ID bf6a7f59-5a10-49fe-9e57-19e3ba202918RxCUI 861635UNII 4S9CL2DY2H, P8Y54F701RUPC 0368462281697
- Pharmacologic class
- alpha-Adrenergic Agonist; beta-Adrenergic Blocker
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Ophthalmic products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N468462028132followed by a unit qualifier and the quantityPackage 68462-0281-32. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
Brimonidine tartrate and timolol maleate ophthalmic solution is indicated for the reduction of elevated intraocular pressure (IOP) in patients with glaucoma or ocular hypertension who require adjunctive or replacement therapy due to inadequately controlled IOP. The IOP-lowering of brimonidine tartrate and timolol maleate ophthalmic solution dosed twice a day was slightly less than that seen with the concomitant administration of 0.5% timolol maleate ophthalmic solution dosed twice a day and 0.2% brimonidine tartrate ophthalmic solution dosed three times per day. Brimonidine tartrate and timolol maleate ophthalmic solution is a combination of brimonidine tartrate, an alpha-adrenergic receptor…
Excerpt only. Read the full label for complete information.